Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1989; Volume 35,Issue 1
  • You have access
    Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
    J M Musacchio, M Klein and J J Paturzo
    Molecular Pharmacology January 1989, 35 (1) 1-5;
  • You have access
    Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
    S H Burstein, K Hull, S A Hunter and J Shilstone
    Molecular Pharmacology January 1989, 35 (1) 6-9;
  • You have access
    Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
    J M Lunetta, K Sugiyama and M A Correia
    Molecular Pharmacology January 1989, 35 (1) 10-17;
  • You have access
    Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    J S Fine, T A Gasiewicz and A E Silverstone
    Molecular Pharmacology January 1989, 35 (1) 18-25;
  • You have access
    Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
    J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
    Molecular Pharmacology January 1989, 35 (1) 26-33;
  • You have access
    Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
    P C Francel, J F Keefer and G Dawson
    Molecular Pharmacology January 1989, 35 (1) 34-38;
  • You have access
    Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    M McKinney, D Anderson and L Vella-Rountree
    Molecular Pharmacology January 1989, 35 (1) 39-47;
  • You have access
    Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    S B Hwang, M H Lam and A H Hsu
    Molecular Pharmacology January 1989, 35 (1) 48-58;
  • You have access
    Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
    M O Karlsson and A Neil
    Molecular Pharmacology January 1989, 35 (1) 59-66;
  • You have access
    Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
    M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
    Molecular Pharmacology January 1989, 35 (1) 67-74;
  • You have access
    Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
    C Czajkowski, T T Gibbs and D H Farb
    Molecular Pharmacology January 1989, 35 (1) 75-84;
  • You have access
    Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
    C S Wu and J T Yang
    Molecular Pharmacology January 1989, 35 (1) 85-92;
  • You have access
    Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
    G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
    Molecular Pharmacology January 1989, 35 (1) 93-97;
  • You have access
    Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
    M A Vazquez-Padua, K Kunugi and P H Fischer
    Molecular Pharmacology January 1989, 35 (1) 98-104;
  • You have access
    Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    J M Ford, W C Prozialeck and W N Hait
    Molecular Pharmacology January 1989, 35 (1) 105-115;
  • You have access
    Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
    J M Thomas and B B Hoffman
    Molecular Pharmacology January 1989, 35 (1) 116-124;
  • You have access
    Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    R F Cox and B L Waszczak
    Molecular Pharmacology January 1989, 35 (1) 125-131;
  • You have access
    Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
    A H Cheung, I S Sigal, R A Dixon and C D Strader
    Molecular Pharmacology January 1989, 35 (1) 132-138;
  • You have access
    Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    P H Roseboom and M E Gnegy
    Molecular Pharmacology January 1989, 35 (1) 139-147;
  • You have access
    Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
    J Halpert, J Y Jaw and C Balfour
    Molecular Pharmacology January 1989, 35 (1) 148-156;
  • You have access
    Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
    J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
    Molecular Pharmacology January 1989, 35 (1) 157-163;
  • You have access
    Characterization of ligand binding to mitochondrial benzodiazepine receptors.
    J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
    Molecular Pharmacology January 1989, 35 (1) 164-172;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 1
1 Jan 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics